Skip to main content

Savara Inc

SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001160308

No open-market purchases or sales by Savara Inc insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Members of Congress who traded SVRA

No member of Congress has reported a trade in Savara Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.